Please use this identifier to cite or link to this item: https://doi.org/10.1111/tid.13930
DC FieldValue
dc.titleComparative outcomes after early Sotrovimab administration in vaccinated and unvaccinated kidney transplant recipients with SARS-CoV-2 infection during the Delta and Omicron BA.1 surges
dc.contributor.authorVathsala, Anantharaman
dc.contributor.authorSomani, Jyoti
dc.contributor.authorRoss D'Costa, Matthew
dc.contributor.authorLum, Lionel
dc.contributor.authorWong, Emmett Tsz-Yeung
dc.contributor.authorSran, Hersharan Kaur
dc.date.accessioned2023-08-22T00:18:58Z
dc.date.available2023-08-22T00:18:58Z
dc.date.issued2022-12
dc.identifier.citationVathsala, Anantharaman, Somani, Jyoti, Ross D'Costa, Matthew, Lum, Lionel, Wong, Emmett Tsz-Yeung, Sran, Hersharan Kaur (2022-12). Comparative outcomes after early Sotrovimab administration in vaccinated and unvaccinated kidney transplant recipients with SARS-CoV-2 infection during the Delta and Omicron BA.1 surges. TRANSPLANT INFECTIOUS DISEASE 24 (6). ScholarBank@NUS Repository. https://doi.org/10.1111/tid.13930
dc.identifier.issn1398-2273
dc.identifier.issn1399-3062
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/244448
dc.language.isoen
dc.publisherWILEY
dc.sourceElements
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectImmunology
dc.subjectInfectious Diseases
dc.subjectTransplantation
dc.typeLetter
dc.date.updated2023-08-21T08:45:01Z
dc.contributor.departmentMEDICINE
dc.description.doi10.1111/tid.13930
dc.description.sourcetitleTRANSPLANT INFECTIOUS DISEASE
dc.description.volume24
dc.description.issue6
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Comparative outcomes after early Sotrovimab administration in vaccinated and unvaccinated kidney transplant recipients with .pdf152.13 kBAdobe PDF

CLOSED

Published

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.